Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.

The human ether-a-go-go-related gene (hERG) channel, a member of a family of voltage-gated potassium (K(+)) channels, plays a critical role in the repolarization of the cardiac action potential. The reduction of hERG channel activity as a result of adverse drug effects or genetic mutations may cause QT interval prolongation and potentially leads to acquired long QT syndrome. Thus, screening for hERG channel activity is important in drug development. Cardiotoxicity associated with the inhibition of hERG channels by environmental chemicals is also a public health concern. To assess the inhibitory effects of environmental chemicals on hERG channel function, we screened the National Toxicology Program (NTP) collection of 1408 compounds by measuring thallium influx into cells through hERG channels. Seventeen compounds with hERG channel inhibition were identified with IC(50) potencies ranging from 0.26 to 22μM. Twelve of these compounds were confirmed as hERG channel blockers in an automated whole cell patch clamp experiment. In addition, we investigated the structure-activity relationship of seven compounds belonging to the quaternary ammonium compound (QAC) series on hERG channel inhibition. Among four active QAC compounds, tetra-n-octylammonium bromide was the most potent with an IC(50) value of 260nM in the thallium influx assay and 80nM in the patch clamp assay. The potency of this class of hERG channel inhibitors appears to depend on the number and length of their aliphatic side-chains surrounding the charged nitrogen. Profiling environmental compound libraries for hERG channel inhibition provides information useful in prioritizing these compounds for cardiotoxicity assessment in vivo.

[1]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Holck,et al.  Identification and characterization of quaternary ammonium compound resistant staphylococci from the food industry. , 1999, International journal of food microbiology.

[3]  E. Winer,et al.  High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine. , 1992, Journal of the National Cancer Institute.

[4]  Ruili Huang,et al.  Compound Cytotoxicity Profiling Using Quantitative High-Throughput Screening , 2007, Environmental health perspectives.

[5]  Ruili Huang,et al.  Identification of chemical compounds that induce HIF-1alpha activity. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  F. Collins,et al.  Transforming Environmental Health Protection , 2008, Science.

[7]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[8]  S. Richard Vascular Effects of Calcium Channel Antagonists: New Evidence , 2012, Drugs.

[9]  M. Xia,et al.  State-dependent inhibition of L-type calcium channels: cell-based assay in high-throughput format. , 2004, Analytical biochemistry.

[10]  H. Katus,et al.  Inhibition of cloned HERG potassium channels by the antiestrogen tamoxifen , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[11]  Jamie I Vandenberg,et al.  Drug Binding to the Inactivated State Is Necessary but Not Sufficient for High-Affinity Binding to Human Ether-à-go-go-Related Gene Channels , 2008, Molecular Pharmacology.

[12]  T. Narahashi,et al.  Interactions of tetramethrin, fenvalerate and DDT at the sodium channel in rat dorsal root ganglion neurons , 1996, Brain Research.

[13]  J. García-Sancho,et al.  Agonist-induced Ca2+ influx in human neutrophils is secondary to the emptying of intracellular calcium stores. , 1991, The Biochemical journal.

[14]  W. Crinnion Chlorinated pesticides: threats to health and importance of detection. , 2009, Alternative medicine review : a journal of clinical therapeutic.

[15]  J. García-Sancho,et al.  High affinity inhibition of Ca(2+)-dependent K+ channels by cytochrome P-450 inhibitors. , 1992, The Journal of biological chemistry.

[16]  B. Tunctan,et al.  Effects of econazole on receptor-operated and depolarization-induced contractions in rat isolated aorta. , 2000, Life sciences.

[17]  H. Katus,et al.  Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy , 2010, Heart.

[18]  P. Kuchel,et al.  The HERG K+ channel: progress in understanding the molecular basis of its unusual gating kinetics , 2004, European Biophysics Journal.

[19]  M. I. Perez,et al.  Blood pressure lowering efficacy of reserpine for primary hypertension. , 2009, The Cochrane database of systematic reviews.

[20]  C. Napolitano,et al.  Torsade de Pointes , 2012, Drugs.

[21]  J. Warmke,et al.  A family of potassium channel genes related to eag in Drosophila and mammals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T J Campbell,et al.  HERG K+ channels: friend and foe. , 2001, Trends in pharmacological sciences.

[23]  Shivaji Srivastava,et al.  Toxicological effects of malachite green. , 2004, Aquatic toxicology.

[24]  Chris Winder,et al.  The toxicity of commercial jet oils. , 2002, Environmental research.

[25]  M. Lazdunski,et al.  HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers. , 1998, Molecular pharmacology.

[26]  D. Wray The roles of intracellular regions in the activation of voltage-dependent potassium channels , 2004, European Biophysics Journal.

[27]  Gea-Ny Tseng,et al.  IKr: The hERG Channel , 2001 .

[28]  Paul B Bennett,et al.  High throughput ion-channel pharmacology: planar-array-based voltage clamp. , 2003, Assay and drug development technologies.

[29]  P. Maxwell,et al.  HIF-1, An Oxygen and Metal Responsive Transcription Factor , 2004, Cancer biology & therapy.

[30]  A. D. Russell,et al.  Antiseptics and Disinfectants: Activity, Action, and Resistance , 2001, Clinical Microbiology Reviews.

[31]  O. Pongs Structural basis of voltage-gated K+ channel pharmacology. , 1992, TIPS - Trends in Pharmacological Sciences.

[32]  R. Shah,et al.  Can pharmacogenetics help rescue drugs withdrawn from the market? , 2006, Pharmacogenomics.

[33]  Heike Wulff,et al.  International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels , 2005, Pharmacological Reviews.

[34]  A. Sasco,et al.  The multitude and diversity of environmental carcinogens. , 2007, Environmental research.

[35]  Huimin Tao,et al.  Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds. , 2004, Assay and drug development technologies.

[36]  A. Zou,et al.  Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain , 2007, Acta Pharmacologica Sinica.

[37]  A. Camm,et al.  Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. , 2003, Cardiovascular research.

[38]  Jianming Xu,et al.  Involvement of Caveolin in Probucol-Induced Reduction in hERG Plasma-Membrane Expression , 2011, Molecular Pharmacology.

[39]  Ruili Huang,et al.  A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel. , 2009, Analytical biochemistry.

[40]  A. Cavalli,et al.  Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. , 2002, Journal of medicinal chemistry.

[41]  Effect of oral administration of 1,3-diphenylguanidine on sperm morphology and male fertility in mice. , 1992, Toxicology.

[42]  G. Tseng I(Kr): the hERG channel. , 2001, Journal of molecular and cellular cardiology.

[43]  B. McCrindle,et al.  Usefulness of mitral regurgitation as a marker of increased risk for death or cardiac transplantation in idiopathic dilated cardiomyopathy in children. , 2011, The American journal of cardiology.

[44]  E. Kaplinsky,et al.  Q-T prolongation and polymorphous ("torsade de pointes") ventricular arrhythmias associated with organophosphorus insecticide poisoning. , 1982, The American journal of cardiology.

[45]  Melvin E Andersen,et al.  Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[46]  P. Stanfield Tetraethylammonium ions and the potassium permeability of excitable cells. , 1983, Reviews of physiology, biochemistry and pharmacology.

[47]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[48]  M. Zoratti,et al.  Contribution of voltage‐gated potassium channels to the regulation of apoptosis , 2010, FEBS letters.

[49]  J. Triedman,et al.  Relation of left ventricular dyssynchrony measured by cardiac magnetic resonance tissue tracking in repaired tetralogy of fallot to ventricular tachycardia and death. , 2011, The American journal of cardiology.